Evidence map›Paper›PMID 38496518›Full record

ArticlebioRxiv : the preprint server for biology2024

Rare Variable

Paul Ogongo, Liya Wassie, Anthony Tran, Devin Columbus, Lisa Sharling, Gregory Ouma, Samuel Gurrion Ouma, Kidist Bobosha, Cecilia S Lindestam Arlehamn, Neel R Gandhi and 7 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Paul OgongoDivision of Experimental Medicine, University of California, San Francisco, CA, USA.
Liya WassieMycobacterial Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Anthony TranDivision of Experimental Medicine, University of California, San Francisco, CA, USA.
Devin ColumbusDivision of Experimental Medicine, University of California, San Francisco, CA, USA.
Lisa SharlingDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Gregory OumaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Samuel Gurrion OumaCenter for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Kidist BoboshaMycobacterial Disease Research Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Cecilia S Lindestam ArlehamnCenter for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0001-7302-8002
Neel R GandhiDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Sara C AuldDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Jyothi RengarajanDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.
Cheryl L DayEmory Vaccine Center, Emory University, Atlanta, GA, USA.
John D AltmanEmory Vaccine Center, Emory University, Atlanta, GA, USA.
Henry M BlumbergDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Joel D ErnstDivision of Experimental Medicine, University of California, San Francisco, CA, USA.
TBRU ASTRa Study Group
Emory University · USUniversity of California, San Francisco · USArmauer Hansen Research Institute · ETKenya Medical Research Institute · KELa Jolla Institute for Immunology · US

Funding

Role of antigen-specific T cell responses in the control of TBU19AI111211 · NIAID · EMORY UNIVERSITY · PI BLUMBERG, HENRY M, ERNST, JOEL D. · 2014 to 2020
$20.1M
Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Neel Rajnikant Gandhi · 2022 to 2026
$5.8M
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigensR01AI173002 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joel D. Ernst · 2023 to 2026
$3.4M
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global HealthK24AI114444 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2014 to 2023
$1.8M
NIAID NIH HHS K24 AI114444NIAID NIH HHS P30 AI168386NIAID NIH HHS R01 AI173002NIAID NIH HHS U19 AI111211
6 · The paper itself

Abstract

CD4 T cells are essential for immunity to

Identifiers

PMID38496518
PMCPMC10942433
OpenAlexW4392613208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.